Skip to search formSkip to main contentSkip to account menu

Recombinant MAGE-3.1 Antigen

Known as: MAGE-3, MAGE-3.1, MAGEA3 
A recombinant tumor-specific melanoma antigen. Vaccination with recombinant MAGE-3.1 antigen may induce a host immune response against MAGE… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2011
2011
Epigenetic regulation of genes involves the coordination of DNA methylation and histone modifications to maintain transcriptional… 
2003
2003
PURPOSE Vaccine-induced antitumor CD8+ T-cell responses are believed to play an important role in increasing resistance to… 
2002
2002
Cancer/testis‐antigens (CTA), a novel and expanding family of immunogenic proteins detected by serological screening of… 
2002
2002
HLA‐transgenic mice have been developed to facilitate studies of HLA‐restricted cytotoxic responses, e.g., for the identification… 
Highly Cited
2000
Highly Cited
2000
The level of expression of melanoma antigens (MA) may modulate the host immunologic response. Thus, the accurate measurement of… 
2000
2000
Dendritic cells (DCs) are the most potent inducers of immune reactions. Genetically modified DCs, which express tumor-associated… 
Highly Cited
1997
Highly Cited
1997
We have established a sensitive ELISPOT assay measuring interferon γ (IFN γ) release on a single‐cell basis to detect influenza… 
1997
1997
Development of effective cancer vaccines would help prevent and control tumor progression. A novel approach of immunizing against… 
1996
1996
MAGE‐1 and MAGE‐3 or ‐6 are genes encoding melanoma‐rejection antigens recognized by cytotoxic T lymphocytes in an HLA‐AI… 
1996
1996
The amino acid sequence of the protein encoded by the gene MAGE‐3was screened for peptides containing the binding motif for HLA…